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Abstract
Background: While RNA-sequencing (RNA-seq) is becoming a powerful technology in transcriptome profiling, one
significant shortcoming of the first-generation RNA-seq protocol is that it does not retain the strand specificity of
origin for each transcript. Without strand information it is difficult and sometimes impossible to accurately quantify
gene expression levels for genes with overlapping genomic loci that are transcribed from opposite strands. It has
recently become possible to retain the strand information by modifying the RNA-seq protocol, known as strand-specific
or stranded RNA-seq. Here, we evaluated the advantages of stranded RNA-seq in transcriptome profiling of whole blood
RNA samples compared with non-stranded RNA-seq, and investigated the influence of gene overlaps on gene
expression profiling results based on practical RNA-seq datasets and also from a theoretical perspective.
Results: Our results demonstrated a substantial impact of stranded RNA-seq on transcriptome profiling and gene
expression measurements. As many as 1751 genes in Gencode Release 19 were identified to be differentially expressed
when comparing stranded and non-stranded RNA-seq whole blood samples. Antisense and pseudogenes
were significantly enriched in differential expression analyses. Because stranded RNA-seq retains strand information of a
read, we can resolve read ambiguity in overlapping genes transcribed from opposite strands, which provides a more
accurate quantification of gene expression levels compared with traditional non-stranded RNA-seq. In the human
genome, it is not uncommon to find genomic loci where both strands encode distinct genes. Among the over 57,800
annotated genes in Gencode release 19, there are an estimated 19 % (about 11,000) of overlapping genes transcribed
from the opposite strands. Based on our whole blood mRNA-seq datasets, the fraction of overlapping nucleotide bases
on the same and opposite strands were estimated at 2.94 % and 3.1 %, respectively. The corresponding theoretical
estimations are 3 % and 3.6 %, well in agreement with our own findings.
Conclusions: Stranded RNA-seq provides a more accurate estimate of transcript expression compared with
non-stranded RNA-seq, and is therefore the recommended RNA-seq approach for future mRNA-seq studies.
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Background
RNA-sequencing (RNA-seq) is a next-generation se-
quencing technique that allows an in-depth look into
the transcriptome [1–3]. Compared with microarray-
based profiling, RNA-seq can detect the expression of
low abundance transcripts and subtle changes under differ-
ent conditions. RNA-seq has a wider dynamic range and
avoids some of the technical limitations in a micro-
array experiment such as varying probe performance,
cross-hybridization, limited dynamic range of individual
probes, and nonspecific hybridization [4, 5]. RNA-seq is
not limited to known transcripts and thus delivers unbiased
and unprecedented information about the transcriptome
and gene expression levels. With decreasing sequencing
cost, RNA-seq is becoming an attractive approach to pro-
file gene expression levels or specific transcript abundance,
and to analyze differential gene expression between bio-
logical conditions.
While RNA-seq is emerging as a powerful technology
in transcriptome profiling, one significant shortcoming
of the standard RNA-seq protocol is that it loses the
strand of origin information for each transcript. Synthe-
sis of randomly primed double-stranded cDNA followed
by the addition of adaptors for next-generation sequen-
cing leads to the loss of information on which strand the
original mRNA template is coming from, and without
that information it becomes difficult to accurately deter-
mine gene expression from overlapping genes [6], i.e., those
genes that have at least partially overlapping genomic
coordinates, but are transcribed from opposite strands.
Knowing the strand information of the cDNA is essential
to determine from which of the overlapping genes the
RNA transcript originates.
It is now possible to retain the information pertaining
to strand origin by modifying the standard RNA-seq
protocol; this is known as strand specific RNA-seq, or
stranded RNA-seq. Recently, multiple protocols for
stranded RNA-seq have been published [7–10]. Seven
protocols were comprehensively evaluated by researchers
at the Broad Institute [10] and the authors found marked
differences in strand specificity, library complexity,
evenness and continuity of coverage, agreement with
known annotations and accuracy for expression profiling.
Weighing each method’s performance and ease of use, the
authors identified dUTP second-strand marking [7] as one
of the leading protocols (Fig. 1). The dUTP second-strand
marking method, or dUTP method for short [7], uses
dUTPs instead of dTTPs during the synthesis of the
second strand in the cDNA synthesis step of sequen-
cing library preparation. Prior to polymerase chain re-
action (PCR) amplification, the second strand, harboring
uracils, is degraded using uracil-N-glycosylase. With the
second strand degraded, only the first strand is amplified in
the subsequent PCR. This protocol was evaluated as super-
ior in terms of both its simplicity and the data quality [10].
According to the protocol in Fig. 1, because the sequence
reads generated from the dUTP method are reverse com-
plementary to the originating mRNA transcripts, the strand
information is retained throughout the sequencing process.
This new methodology is now emerging as a powerful
tool for transcript discovery, genome annotation, and ex-
pression profiling [11, 12]. Previous reports demonstrated
Fig. 1 Non-stranded versus stranded RNA-seq protocol. The stranded protocol differs from the non-stranded protocol in two ways. First, during
cDNA synthesis, the second-strand synthesis continues as normal except the nucleotide mix includes dUTPs instead of dTTPs. Second, after library
preparation, a second-strand digestion step is added. This step ensures that only the first strand survives the subsequent PCR amplification step
and hence the strand information of the libraries
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that data from stranded libraries are more reliable than
data from non-stranded libraries and can correctly evalu-
ate the expression of both antisense RNA and other over-
lapping genes [11]. Maintaining strand orientation also
allows identification of antisense expression, an important
mediator of gene regulation. The ability to capture the
relative abundance of both sense and antisense expression
provides insight into regulatory interactions that might
otherwise be missed [12]. With the ability to unlock
new information on global gene expression, stranded
RNA-seq holds the key to a deeper understanding of the
transcriptome.
To allow for efficient transcript/gene detection, highly
abundant ribosomal RNAs (rRNAs) must be removed from
total RNA before sequencing [13]. One standard solution is
to enrich for the polyadenylated (polyA) tail attached RNA
transcripts (so-called mRNA-Seq) with oligo (dT) primers.
Another approach removes rRNA through hybridization
capture of rRNA followed by binding to magnetic beads for
subtraction. For most transcriptome studies, mRNA-seq is
commonly used, as the sequencing depth required is lower
when focusing only on the protein coding fraction of the
transcriptome. In this paper, we performed a side-by-side
comparison of stranded and non-stranded mRNA-seq by
sequencing the same samples using both protocols. We in-
vestigated and characterized gene overlap in our RNA-seq
dataset, as well as performed theoretical analysis of the
number of overlapping genes based on genome annotation
in Gencode Release 19 [14]. We demonstrate that stranded
RNA-seq improves the accuracy of gene quantification,
and this is especially critical for accurate gene expression
quantification of antisense genes.
Results and discussion
The sample preparation, sequencing, and data analysis are
detailed in the Methods section. In brief, we collected
blood from five healthy donors into Paxgene RNA tubes
and pooled all samples. Four replicate samples (labeled as
PFE1, PFE2, PFE3, and PFE4) were sequenced using both
stranded (denoted as S) and non-stranded (denoted as NS)
protocols. We note that these samples are considered
technical replicates and therefore represent an ideal
scenario with minimal variation. In this paper, we use the
name convention “Sample_Protocol” to label each RNA-
seq dataset. For instance, PFE1_S represents the sample
PFE1 sequenced by stranded RNA-seq. For RNA-seq data
analysis, we implemented an in-house pipeline in the Pfi-
zer High Performance Computing environment as shown
in Fig. 2. Raw sequence reads were mapped to human
genome hg19 by STAR [15], and the uniquely mapped
reads were counted by featureCounts [16] in the Subread
package. Multiple mapped reads were excluded from
counting, and then differential analysis was performed
by the R packages edgeR [17] and Limma/voom [18].
Gene quantification and differential analysis results are
dependent upon the initial choice of gene annotation
[19–21]. In the previous paper [21], we evaluated the
impact of different annotations on RNA-seq data ana-
lysis, including RefGene [22], UCSC [23], and Ensembl
[24]. Gencode annotation [14] is based upon Ensembl
but with improved coverage and accuracy, and it is used
by the ENCODE consortium as well as many other
projects (e.g., 1000 Genomes) as the reference gene set. In
this evaluation, we therefore also chose the Gencode
annotation, and the conclusions in this paper should
largely (or for the most part) hold true when other gene
annotations are used (data not shown).
Read mapping and counting
Each replicate sample was sequenced by both non-
stranded and stranded RNA-seq. The summaries for
sequencing depth, mapping, and counting are shown in
Fig. 3 and listed in Additional file 1: Table S1. For each
sequenced library, there are over 60M paired-end reads
(Fig. 3a) available for alignment and gene quantification.
Overall, about 87–91 % of reads uniquely map to gen-
omic regions, while approximately 3.5 % of reads map
equally well to multiple locations. A remainder of ~5–
8 % of reads fails to map to any locus in the human gen-
ome (Fig. 3b). In principle, non-stranded and stranded
RNA-seq should have comparable mapping statistics for
the same sample. However, as shown in Fig. 3b, the per-
centage of uniquely mapped reads in non-stranded
RNA-seq is slightly higher than in stranded RNA-seq.
Fig. 2 Workflow for RNA-seq data analysis
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After further investigation, we found that the average
fragment size in non-stranded libraries is ~30 bp longer
than in stranded sequencing. This may be caused by spe-
cial treatment and the PCR enzyme in Illumina’s kit. As
a result, in stranded sequencing, there are an estimated
4 % of fragments whose sizes are even shorter than the
sequence read length used in this study (i.e., 100 bp).
Therefore, sequence reads derived from short fragments
end up contaminated with nucleotide bases from adapters
and thus might fail to map to the genome because of too
many mismatches.
As shown in Fig. 3c, the majority of uniquely mapped
reads are counted towards genes in both stranded and
non-stranded RNA-seq as expected for mRNA-seq.
About 7–8 % of mapped reads do not match to any gene
and thus are excluded from gene quantification. The am-
biguous reads in Fig. 3c are those reads mapped to over-
lapping gene regions, either on the same strand or from
the opposite strands. To highlight the genomic loci with
genes overlapping on the two opposite strands, the read
ambiguity in Fig. 3c is zoomed out and shown in Fig. 3d.
The read ambiguity in stranded RNA-seq arises only from
overlapping genes transcribed from the same strand. In
contrast, for non-stranded RNA-seq, the ambiguity arises
from both the overlapping genes on the same strand and
also from the opposite strands. For the four stranded
Fig. 3 Metrics for RNA-seq. a) The sequencing library size; b) the mapping summaries for sequence reads; c) the counting summaries for uniquely
mapped reads; d) the ambiguous reads arising from gene overlapping; on average, the percentage of ambiguous reads drops approximately
3.1 % from non-stranded to stranded RNA-seq, and this drop roughly represents the overlapping arising from opposite strands; e) the correlation
for gene expression profile among those eight samples; the samples are clearly clustered by sequencing protocol; f) the boxplot of
gene expression
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RNA-seq samples, the read ambiguity is an average of
2.94 % (Fig. 3d and Additional file 1: Table S1), while for
the four non-stranded RNA-seq samples it is 6.1 % (Fig. 3d
and Additional file 1: Table S1). Compared with non-
stranded RNA-seq, the percentage of ambiguous reads in
stranded RNA-seq drops by approximately 3.1 %, and this
drop roughly represents the magnitude of gene overlap
from the two opposite strands. As we demonstrate below,
the gene overlap from our RNA-seq dataset is also con-
sistent with our theoretical estimation.
The correlation for gene expression levels among the
eight samples studied is plotted in Fig. 3e. The samples
are clearly clustered by sequencing protocol, and while
the correlation for samples prepared with the same proto-
col is nearly 1, the correlation for samples sequenced by
the two different protocols is around 0.93. The correlation
plot in Fig. 3e indicates underlying gene expression profile
differences between the stranded and non-stranded RNA-
seq methods. The distribution of gene expression in each
sample is shown in the boxplot in Fig. 3d (note the y-axis
is log2(RPKM)). Overall, the distribution across samples is
very similar. The 1st quartile, median, and 3rd quartile are
approximately 0.77 RPKM, 3.0 RPKM, and 9.6 RPKM, re-
spectively. The gene expression distribution plot in Fig. 3d
is a good reference to evaluate whether gene expression is
relatively low, medium, or high.
Theoretical estimate of frequency and magnitude of gene
overlap
Every gene in Gencode Release 19 has genomic coordi-
nates, and the frequency of overlapping genes can thus be
calculated (Fig. 4 and Additional file 1: Tables S2 and S3).
There are more than 57,800 annotated genes in Gencode
Release 19. Figure 4a shows the overlaps at the gene level.
For all chromosomes, the frequency of opposite strand
overlap is greater than the same strand overlap in terms of
the number of overlapping genes. On average, approxi-
mately 9 % of genes overlap at the same strand, while for
the overlap from opposite strands, the overlap increases to
approximately 19 %. Stranded RNA-seq can resolve the
Fig. 4 Estimated gene overlaps in Gencode Release 19. a) The same strand and opposite strand overlaps at the gene level; about 19 % of genes
overlap with one or more genes at the opposite strand; b) the overlaps at the nucleotide base level. On average, the estimated overlapping at
the same and opposite strands are 3 % and 3.6 %, respectively, and agree well with the practical RNA-seq dataset shown in Fig. 3d
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read ambiguity in overlapping genes that are transcribed
from opposite strands. Accordingly, 19 % of genes (i.e.,
11,000 genes) in Gencode Release 19 are expected to have
more accurate gene quantification in stranded RNA-seq
than in non-stranded RNA-seq. As more and more novel
genes are discovered in the genome, it is expected that
additional genes will have overlapping genomic loci.
Genomic loci with longer overlapping genes will produce
more transcript reads that cannot be uniquely assigned to
either strand when using non-stranded RNA-seq. To fur-
ther estimate the impact of overlap on gene quantification,
we quantified the overlaps at the nucleotide level (Fig. 4b).
On average, the estimated overlaps at the same and oppos-
ite strands are 3 % and 3.6 %, respectively, and this agrees
very well with our practical RNA-seq data. According to
our stranded RNA-seq dataset, the read ambiguity in over-
lapping genes at the same strand is 2.94 % (Fig. 3d and
Additional file 1: Table S1), which is very close to the the-
oretical estimation (Fig. 4b and Additional file 1: Table S3).
In Fig. 3d, the opposite strand overlap in our actual RNA-
seq dataset is 3.1 %, slightly lower than the theoretical
3.6 % (Fig. 4b). It should be pointed out that the theoretical
estimation is based upon the assumption that all genes in
the Gencode annotation database are uniformly expressed.
In an actual RNA sample, the expression level varies
from gene to gene, including genes that are not expressed
at all. In addition, with our chosen sequencing protocol, a
transcript is not picked up if it does not have a polyA tail
at the 3’ end. Still, the theoretical estimation in Fig. 4b
explains very well the counting summary for ambiguous
reads in Fig. 3d and Additional file 1: Table S1. In practice,
the overlap in actual samples may be higher or lower than
our theoretical estimation depending upon the gene ex-
pression profile in a sample.
We also quantified the degree of gene overlap by ana-
lyzing all pairs of overlapping genes. First, we identified
the common or overlapping exon regions between any
two overlapping genes. Then, the shorter gene was
selected and the ratio (i.e., the overlapping percentage)
was calculated by dividing the length of overlapping
exons by the exon length of the shorter gene. A total of
6582 overlapping gene pairs were identified from oppos-
ite strands and the number was 3718 at the same strand.
The histograms and cumulative distributions of overlaps
are shown in Fig. 5. The histograms (Fig. 5a and b) indi-
cate the extent of overlap ranges from partial to complete.
There are 582 genes that are 100 % contained within other
genes at the same strand, while 654 genes are completely
contained within the same genomic locus of another gene
from the opposite strand. The cumulative distributions in
Fig. 5c and 5d describe the probability of having an over-
lapping gene pair with an overlap less than or equal to a
given threshold. For the same strand overlap, the medium
overlap is approximately 47.4 %, while for the opposite
Fig. 5 Histograms and cumulative distributions for all pairs of overlapping genes. The ratio (i.e., the overlapping percentage) for each pair of
genes is calculated by dividing the length of overlapping exons by the exon length of the shorter gene of the pair
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strand overlap, its medium is approximately 18.7 %. In
general, the magnitude of overlap for the same strand is
greater than the overlap from the opposite strands.
Differential analysis
The scatter plots of the gene expression profiles for the
four replicate samples are shown in Fig. 6. For compari-
son, the all-against-all scatter plots for stranded and
non-stranded samples are shown in Additional file 1:
Figures S1 and S2, respectively. For technical replicates
sequenced by the same protocol, all data points are
arrayed clearly along the diagonal lines with a relatively
large variation only for genes with low expression. How-
ever, when comparing the same samples sequenced by
the two different protocols, there are many genes that
are far away from the diagonal lines along the length of
the axis in Fig. 6. For samples PFE1, PFE2, PFE3 and
PFE4, the scatterplot patterns are very consistent as ex-
pected from technical replicates. As observed in Fig. 6,
for a large number of genes, the sequencing protocol has
a dramatic impact on the final gene quantification
results. It is not unusual that there are genes whose
expression levels are high in one protocol, but very low
or even zero in the other protocol.
To identify genes with large expression differences be-
tween stranded and non-stranded RNA-seq, we performed
a differential expression analysis using R packages edgeR
[17] and Limma/voom [18]. The raw read counts generated
by featureCounts [16] were normalized by TMM (trimmed
mean of M-values) in edgeR first, followed by standard dif-
ferential analysis. The statistical test results are summarized
in Fig. 7. Each point in the plot corresponds to a gene. The
x-axis represents the log2 fold change of stranded versus
non-stranded, while the y-axis (-log10(Adjusted PValue))
corresponds to the significance of statistical test. A total of
1751 significant genes were identified to be differentially
expressed (DE) and are colored in red in Fig. 7. The criteria
for significance are as follows: (1) an adjusted p value <0.05
(the horizontal dotted line in Fig. 7); and (2) a fold change
greater than 1.5 (the two vertical dotted lines in Fig. 7). Of
those significant genes, 941 genes (top right corner) have
higher expression in stranded than in non-stranded
sequencing, while 841 genes (top left corner) are down
regulated, having lower expression in stranded than in
non-stranded RNA-seq. The large number of differential
expression genes in Fig. 7, together with the scatter plots in
Fig. 6 and the correlation plot in Fig. 3e, clearly demon-
strates the substantial impact of sequencing protocols on
gene quantification.
A gene is considered to be expressed if its maximal
expression across all eight samples is greater than 1 CPM
(count per million), and accordingly, a total of 16,443
expressed genes survived this filtering. All genes that have
appreciable expression and those 1751 DE genes in Fig. 7
can be further broken down into the gene categories
shown in Table 1. The detailed description of each gene
category from Gencode annotation was described previ-
ously [25]. As shown in Table 1 and Additional file 1:
Figure S3, over 80 % of expressed genes are protein cod-
ing, while both antisense genes and pseudogenes account
for roughly 5 % each. However, for DE genes, the percent
of protein coding drops to 46 %, but both the antisense
and pseudogene categories increase to ~20 % each. Thus,
the differential expression we observe is associated with
gene type. Globally, 10.65 % of genes are differentially
expressed when comparing the stranded and the non-
Fig. 6 Scatter plots of gene expression profiles between stranded and non-stranded RNA-seq. For samples PFE1, PFE2, PFE3, and PFE4, the scattering
patterns are consistent. While the majority of genes are arrayed along the diagonal lines, there are still many genes whose expression levels were
dramatically impacted by sequencing protocols. The x- and y-axis represent Log2(RPKM)
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stranded RNA-seq data. However, for antisense genes and
pseudogenes, the ratios jump to 39 % and 43 %, respect-
ively (Table 1 and Fig. 8a). To test whether the apparent
enrichment of antisense genes and pseudogenes is statis-
tically significant, the built-in binomial proportions test
prop.test in R was used. The calculated p values are smaller
than 2.2E-16 for both gene categories, indicating the
enrichment is not by chance.
Next, we explored the association between differential
analysis results and sequencing protocol. Every gene (dot)
in Fig. 7 is either a DE (colored in red) or Non_DE (non-
differential expression, colored in black) gene, and these
genes are then further classified into one of two classes
(i.e., “No” and “Yes”) based upon whether it overlaps with
one or more genes transcribed from opposite strands. The
overlap for each gene type is summarized in the last four
columns in Table 1. The proportion of gene overlaps for
all genes, DE genes, and Non_DE genes are shown in
Fig. 8b. For protein coding, antisense and lincRNA gene
types, the overlap is significantly higher in DE genes than
in Non_DE genes. For instance, 87 % of antisense DE
genes are overlapping genes, while only 60 % of antisense
genes are overlapping genes in the Non_DE genes. For
pseudogenes, no apparent association is observed, and
confirmed by statistical test. To accept or reject the null
hypothesis that differential expression and gene overlap
are independent, the chi-square test was performed for
the top four gene categories in Table 1. A contingency
table was first prepared from the counts in the last four
columns in Table 1, and then the chisq.test R function was
called to evaluate the significance of the test. All tests re-
port a P value lower than 2.2E-16, except for pseudogene
(P value = 0.96).
As observed in Fig. 8, antisense genes are enriched
substantially in differential expression, and this differen-
tial expression is strongly associated with gene overlap.
The overwhelming majority of antisense DE genes show
higher expression in stranded RNA-seq, and their ex-
pressions in non-stranded RNA-seq are quite often zero
or very low. Antisense transcripts can act as regulatory
elements in the regulation of gene expression [12], and a
number of antisense transcripts are related to various
human disorders [26]. A proper elucidation of the anti-
sense transcriptome and its quantification will reveal
their novel function in regulation of gene expression.
Based on these observations, we have shown that the
stranded RNA-seq is more effective than non-stranded
Fig. 7 Differential analysis results for the comparison between stranded
and non-stranded RNA-seq. Every point in the plot corresponds to a
gene. The x-axis represents the log2 fold change of stranded over
non-stranded, while the y-axis (-log10 (AdjustedPValue)) corresponds to
the significance of a statistical test. All significant genes are
colored in red. The criteria for significance are as follows: (1) an
adjusted p value <0.05 (the horizontal dotted line); and (2) a fold
change greater than 1.5 (the two vertical dotted lines)
Table 1 The association between differential expression and gene overlapping is gene-type dependent
Gene_type Differential analysis Overlapping
All genes DE genes Ratioa
(%)
DE genes Non_DE genes
# % # % No Yes No Yes
Protein_coding 13219 80.39 810 46.26 6.13 226 584 8082 4327
Antisense 924 5.62 363 20.73 39.29 48 315 225 336
Pseudogene 845 5.14 365 20.85 43.20 304 61 398 82
LincRNA 764 4.65 100 5.71 13.09 43 57 571 93
Processed_transcript 182 1.11 36 2.06 19.78 7 29 76 70
Sense_intronic 113 0.69 19 1.09 16.81 12 7 90 4
Other 396 2.41 58 3.31 14.65 53 5 325 13
Total 16443 100 1751 100 10.65 693 1058 9767 4925
aNote: Ratio = (# of DE genes)/(# of All expressed genes). It represents what percentage of genes is differentially expressed. For a gene in each category, it is
either a DE or Non_DE (not differential expression) gene, and then it is further broken into two classes based upon whether it overlaps with one or more genes
transcribed from opposite strands. Therefore, the sum of the last four columns is equal to the total number of genes in that category
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RNA-seq in properly quantifying expression for anti-
sense genes.
The ENCODE project recently performed a survey of
publicly available expression data to identify transcribed
pseudogenes and found over 800 pseudogenes with strong
evidence of transcription [27].
Recent studies have shown that some pseudogenes are
transcribed and contribute to cancer when dysregulated
[28]. In particular, pseudogene transcripts can function
as competing endogenous RNAs [29]. However, reliable
quantification of pseudogene expression remains a chal-
lenging problem for a number of reasons. First, because
parent genes and pseudogenes are highly similar in
nucleotide sequence, short RNA-seq reads derived from
one may align equally well to others. Such reads are fun-
damentally ambiguous in terms of their origin. Second,
some reads may have nearly identical alignment to loca-
tions in the gene and pseudogene, and their mapping is
often determined by the location with the least error in
alignment. This strategy is unreliable and can result in
an incorrect assignment of the read [29]. The enrich-
ment of pseudogenes in differential analysis in Fig. 8a is
hard to explain because the gene overlap from the op-
posite strand seems to not be the cause (see Fig. 8b). Of
those 365 DE pseudogenes, 90 genes have higher expres-
sion in non-stranded RNA-seq, while 275 have higher
expression in stranded RNA-seq. Usually the expression
level for pseudogenes is not high. For those DE pseudo-
genes, the average expression is 3.9 RPKM across all eight
samples, while for protein coding genes, the average is as
high as 31.6 RPKM. We speculated the enrichment for
pseudogenes might arise from (1) the read mapping uncer-
tainty in pseudogenes, (2) the lower expression levels for
pseudogenes, and (3) the additional bias introduced by
sequencing protocols. We checked the read mapping pro-
files for some pseudogenes (unpublished results), and
found that quite often those reads that mapped to pseudo-
genes have mismatches. Because of the intrinsic uncer-
tainty in read mapping, we should be cautious about the
gene quantification and differential analysis results for
pseudogenes.
Exemplary differential expression genes
For a given gene, if stranded and non-stranded RNA-seq
report different expression levels, which one is more
reliable? In principle, the stranded RNA-seq should be
more accurate because additional information (i.e., the
read direction) is used in gene quantification, and the
ambiguous reads in overlapping genes transcribed from
opposite strands are resolved and counted. Below, we
selected a few example genes (i.e., IL24, ICAM4, and
GAPDH) to demonstrate this point. The expressions for
these three genes are shown in bar charts in Fig. 9.
Interleukin (IL) 24 is a secreted protein of the IL10
family, and its expression has been identified in certain
cell types. In vivo, IL24 is predominantly expressed by
skin tissue cells during inflammatory conditions, such as
psoriasis [30]. In non-stranded RNA-seq, this gene has
an expression level as high as approximately 22 RPKM
in whole blood, but stranded RNA-seq reports no
expression at all. The read mapping results in PFE1 are
shown in Fig. 10. All genes, transcripts, and sequence
reads in Fig. 10 are colored in blue if they are in the “+”
strand, and colored in green if in the “−“ strand. Because
too many reads were mapped to the IL24 genomic
region, particularly at the 3′UTR end, only a portion of
mapped reads are shown in the plot. In non-stranded
RNA-seq, all reads mapped to IL24 are counted,
Fig. 8 The association between differential expression and gene overlap is gene-type dependent. a The percentage of genes that are differentially
expressed in each gene category. Antisense and pseudogene are enriched. The y-axis represents percentage. b The dependency between differential
expression and gene overlap from opposite strands. For protein coding, antisense and lincRNA gene types, the overlap is significantly higher in DE
genes than in Non_DE genes
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regardless of their originating genomic strand. IL24 is on
the “+” strand, and thus a sequence read truly originat-
ing from IL24 must be reverse complementary and
mapped to the “−“ strand. Therefore, in stranded RNA-
seq, only those reads mapped to the “−“ strand are
counted. As can be seen, nearly all reads in stranded
RNA-seq are mapped to the “+” strand (Fig. 10). As a re-
sult, those reads are not counted, clarifying why stranded
RNA-seq reports no expression for IL24. The coverage
pattern of sequence reads in Fig. 10 also does not sup-
port that they would originate from IL24 either in
stranded or non-stranded RNA-seq. The uniformity bias
Fig. 10 The mapping profiles for IL24 in Replicate PFE1. In non-stranded RNA-seq, all reads mapped to IL24 are counted regardless if they are in
the forward or reverse strands. However, in stranded RNA-seq, nearly all reads are mapped to the “+” strand and thus not counted because these
reads are not reverse complementary to IL24 in the “+” strand. However, the coverage pattern of sequence reads does not support the sequence
reads mapped to the IL24 genomic region that truly originate from this gene. All genes, transcripts, and sequence reads are colored in blue if they
are in the “+” strand and colored in green if in the “−“ strand
Fig. 9 The gene expression of IL24, ICAM4, and GAPDH in stranded and non-stranded RNA-seq
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in RNA-seq does not explain the extremely uneven cover-
age pattern observed in Fig. 10. Moreover, this cytokine is
not expected to have a high expression in whole blood
RNA-seq [30]. The quantification of IL24 expression in
non-stranded RNA-seq is thus misleading. In contrast, the
result in stranded RNA-seq is more reliable, and biologic-
ally makes sense with previous observations.
Because those reads in Fig. 10 are not derived from
IL24, an obvious question is why so many reads are
mapped to the genomic region of IL24. As we know, our
current gene annotation is neither complete nor com-
prehensive, and it is likely that such reads originate from
a novel gene at the opposite strand of IL24. We cur-
rently do not have a good explanation for these mapped
reads. However, the scenario in Fig. 10 has shown that
stranded RNA-seq is likely more powerful than non-
stranded RNA-seq in detecting potentially novel unan-
notated transcripts from regions in which there is not a
currently annotated gene.
ICAM4 (intercellular adhesion molecule 4) shows mod-
erate expression in whole blood [31]. However, non-
stranded RNA-seq reports no expression for this gene, and
the reason is revealed in Fig. 11. ICAM4 is encoded on the
“+” strand, and it has three alternative splicing transcripts.
It overlaps with another gene CTD-2369P2.8 in the “−“
strand. CTD-2369P2.8 is a manually annotated gene from
the Havana (the Human and Vertebrate Analysis and
Annotation) project, and it is longer than ICAM4. As
observed in Fig. 11, ICAM4 is 100 % contained within
CTD-2369P2.8. In non-stranded RNA-seq, a read mapped
to ICAM4 is simultaneously aligned to CTD-2369P2.8 as
well. The ambiguous reads in overlapping regions are thus
excluded from counting in FeatureCounts, and this ex-
plains the lack of expression for ICAM4 on non-stranded
RNA-seq. The ambiguous reads in overlapping genes in
Fig. 11 can be perfectly resolved using stranded RNA-seq.
By considering the read direction, all reads are assigned to
ICAM4 (but not CTD-2369P2.8), because they are all
reverse complementary to ICAM4. According to our
sequencing protocol, it is impossible for such reads to
originate from CTD-2369P2.8. The gene expression in
stranded RNA-seq also agrees with other supporting
evidence [31], and is again more reliable than in non-
stranded RNA-seq.
For the scenario in non-stranded RNA-seq in Fig. 11, it
does not help if we use a different counting algorithm such
as RSEM (RNA-Seq by Expectation-Maximization) [32].
Despite the fact that RSEM is capable of fully handling
reads that map ambiguously or fall into the gene overlap-
ping regions, it proportionally distributes ambiguous reads
according to the number of unique reads in overlapping
genes. If a gene is completely contained within another
gene, it has no unique read at all. As a consequence, zero
reads are counted to that gene. According to the theoretical
calculation above, there are a total of 582 genes completely
contained with other genes from opposite strands. In short,
the read ambiguity in non-stranded RNA-seq in Fig. 11
cannot be resolved by a purely computational approach,
and stranded RNA-seq is required in this scenario to deter-
mine correct gene expression.
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is
a well-known housekeeping gene with very high expression
Fig. 11 The mapping profiles for ICAM4 (intercellular adhesion molecule 4) in Replicate PFE1. The gene ICAM4 is on the “+” strand, and 100 % contained
within CTD-2369P2.8 in the “−“ strand. In non-stranded RNA-seq, the ambiguous reads in overlapping regions are excluded from counting, which explains
why there is no expression for ICAM4. However, the ambiguous reads can be perfectly resolved in stranded RNA-seq. By considering the read direction,
all reads can be counted to ICAM4 because they are reverse complementary to ICAM4, but not CTD-2369P2.8
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in most cell types and tissues. Compared with stranded
RNA-seq, its expression in non-stranded RNA-seq is in
fact underestimated (Fig. 9). The reason for this underesti-
mation can be easily understood when considering the
gene overlap shown in Additional file 1: Figure S3. All of
the ambiguous reads in the overlapping region originate
only from GAPDH in stranded RNA-seq, thus the expres-
sion for GAPDH in stranded RNA-seq is more accurate
than non-stranded.
Conclusions
In this paper, we performed a side-by-side comparison of
stranded and non-stranded RNA-seq, and investigated the
gene overlap both in our practical whole blood RNA-seq
dataset and from the theoretical perspective. Our study
demonstrates that stranded RNA-seq provides a more ac-
curate estimate of transcript expression compared with
non-stranded RNA-seq and is therefore the recommended
RNA-seq approach for all future mRNA-seq studies.
Methods
We used various freely available open source tools and
implemented an in-house pipeline for stranded and non-
stranded RNA-seq data analyses (Fig. 2). The details on
each step in the data generation and analyses are de-
scribed below.
Blood sample collection, RNA extraction, and globin
mRNA depletion
Peripheral venous blood samples from five healthy male
volunteers were collected in PAXgene Blood RNA tubes
(PreAnalytiX GmbH, BD Biosciences, Mississauga, ON,
Canada). Blood was pooled across subjects to create a
single pooled sample. This pooled blood was dispensed
into a set of approximately 10-mL aliquots. Total RNA
was extracted from four aliquots of pooled blood using
the PAXgene Blood RNA Kit (cat# 762164, Qiagen,
Chatsworth, CA, USA) according to the manufacturer's
protocol. The yield and quality of the isolated RNA
were assessed using a NanoDrop8000 Spectrophotom-
eter (Thermo Scientific, Wilmington, DE, USA) and
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA), respectively. An aliquot of 1.5 mg of
each RNA was further processed with a GlobinClear kit
(cat# AM1980, Life Technologies, Carlsbad, CA, USA) to
remove globin mRNA. After globin mRNA depletion, the
quality and yield of the RNA were assessed again using an
Agilent 2100 Bioanalyzer. Six hundred nanograms of RNA
(post-GlobinClear) were divided into two 300 ng aliquots,
with one aliquot submitted to stranded RNA-seq proces-
sing and the second aliquot submitted to non-stranded
RNA-seq processing.
cDNA library construction and sequencing
For stranded RNA-seq, cDNA libraries were prepared
with a TruSeq stranded mRNA library prep Kit (cat# RS-
122-2101, Illumina, San Diego, CA , USA). For non-
stranded RNA-seq, cDNA libraries were prepared with a
TruSeq RNA sample preparation kit v2 (cat# RS-122-
2001, Illumina). The resulting eight libraries were se-
quenced on a HiSeq 2000 (Illumina) using a paired-end
run (2 × 100 bases). A minimum of 60 M reads were gen-
erated from each library. The clean raw sequence reads in
FASTQ format were analyzed using the pipeline in Fig. 2.
Mapping and counting
The human genome database and gene annotation data-
base were used to map and count sequence reads. Gencode
Release 19 was downloaded from http://www.genco-
degenes.org/releases/19.html. The reads were mapped
to the hg19 reference genome using STAR v2.4.0h
[15]. The detail parameters for the STAR run were
“–runThreadN 8 –alignSJDBoverhangMin 1 –out-
ReadsUnmapped Fastx –outFilterMismatchNoverLmax
0.05 –outFilterScoreMinOverLread 0.90 –outFilterMatchN-
minOverLread 0.90 –alignIntronMax 1000000 –outSAM-
type BAM SortedByCoordinate”. The mapping was
performed on the Pfizer High Performance Computing
cluster. The mapping summaries, such as the percentage
of reads that were uniquely mapped, multiple mapped, or
unmapped, were then collected from the log files of STAR
runs (see Results).
To count reads mapped to individual genes in Gencode,
the program featureCounts [16] was used. FeatureCounts
assigns a read to a feature (a gene) or labels it as matching
to no feature or as ambiguous if it matches more than one
feature and it cannot determine which one it is. The
parameters in featureCounts run were “-p -T 4 -F
GTF -a hg19.gencode.v19.gtf -t exon -g gene_id -s
$Strand -B -C –minReadOverlap 60” (note $Strand
was set to 0 for non-stranded RNA-seq, and 2 for
dUTP second strand marking RNA sequencing protocol).
Only uniquely mapped reads are used in the counting
step. Like the mapping step above, the counting metrics
were collected from the summary file of each feature-
Counts run. Genes that have expression levels less than 1
CPM were labeled as low expressed. If a gene had zero or
low expression across all eight samples, it was omitted
from the correlation and differential expression analysis.
This filtering step was included to reduce the false posi-
tives in the differential analysis [33].
Differential expression analysis
A counts table was generated by featureCounts and then
used for the DE analysis. The differential analysis was per-
formed by R packages edgeR 3.8.5 [17] and Limma/voom
3.22.4 [18]. We compared the stranded versus non-
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stranded sequencing groups. All genes with a fold change
greater than 1.5 and a Benjamini-Hochberg adjusted
p-value smaller than 0.05 were reported as DE genes.
Theoretical estimation of gene overlapping at the same
and opposite strands
The estimation was performed by R package Genomic-
Features 1.18.3 [34]. First, a transcript database (TxDB)
was created from the Gencode annotation in GTF format
by calling R function makeTranscriptDbFromGFF. We then
extracted all exons from TxDb and grouped them by gene.
According to strand information, the genes in each
chromosome were divided into two groups. The over-
laps at the same and opposite strands were quantified
at both gene and nucleotide base levels (see Fig. 4).
For each pair of overlapping genes, for example G1
and G2, the lengths for flattened exons were calcu-
lated and the short gene was selected for calculating
the ratio of overlapping. The histogram and cumula-
tive distribution of overlap were quantified (Fig. 5).
Consent
The protocol for the Pfizer Research Support Program to
collect blood samples from volunteer donors was approved
by the Schulman Associates Institutional Review Board
(IRB#201065670; http://www.sairb.com/Pages/home.aspx).
Written informed consent was obtained from all volunteer
blood donors for the research described and potential pub-
lication thereof. A copy of the written consent is available
for review by the Editor of this journal. Samples from indi-
viduals were coded at the time of collection and then
pooled prior to data generation, removing any possible as-
sociation of analytical measurements with a single donor.
Availability of supporting data and script
All the raw sequencing reads have been submitted to the
NCBI Sequence Read Archive and are available under
accession SRP056985.
The R script to estimate the gene overlap is attached
as Additional file 1: Script 1.
Additional file
Additional file 1:Table S1. Reports the related metrics for all eight RNA-
seq samples, including library sizes, the mapping summaries, and the count-
ing summaries. Tables S2. and S3. Tabulate the overlapping summaries of
Gencode V19 annotation database at both the gene and the nucleotide
base levels, respectively. Figures S1. and S2. Show all-against-all scatter plots
of gene expression profile among RNA-seq samples sequenced by stranded
and non-stranded protocols, respectively. Figure S3. Explains why the
expression level for GAPDH (a well-known housekeeping gene) is
underestimated in non-stranded RNA-seq. Script 1. Contains the R script
to estimate the gene overlap in Gencode Release 19. (PDF 429 kb)
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